You are in: eMedicine Specialties > Ophthalmology > CORNEA Corneal Foreign BodyArticle Last Updated: Nov 2, 2007AUTHOR AND EDITOR INFORMATIONAuthor: Mounir Bashour, MD, CM, FRCS(C), PhD, FACS, Assistant Professor of Ophthalmology, McGill University; Clinical Assistant Professor of Ophthalmology, Sherbrooke University; Medical Director, Cornea Laser and Lasik MD Mounir Bashour is a member of the following medical societies: American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus, American College of International Physicians, American College of Surgeons, American Medical Association, American Society of Cataract and Refractive Surgery, American Society of Mechanical Engineers, American Society of Ophthalmic Plastic and Reconstructive Surgery, Biomedical Engineering Society, Canadian Medical Association, Canadian Ophthalmological Society, Contact Lens Association of Ophthalmologists, International College of Surgeons US Section, Ontario Medical Association, Quebec Medical Association, and Royal College of Physicians and Surgeons of Canada Editors: Kilbourn Gordon III, MD, FACEP, Urgent Care Physician, Primary Medical, Huntington Walk-In and Greenwich Convenient Medical Center; Simon K Law, MD, PharmD, Assistant Professor of Ophthalmology, Jules Stein Eye Institute; Chief of Section of Ophthalmology Surgical Services, Department of Veterans Affairs Healthcare Center, West Los Angeles; Christopher J Rapuano, MD, Professor, Department of Ophthalmology, Jefferson Medical College; Co-Chairman of the Cornea Service, Co-Chairman of Refractive Surgery Department, Wills Eye Hospital; Lance L Brown, OD, MD, Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri; Hampton Roy Sr, MD, Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences Author and Editor Disclosure Synonyms and related keywords: foreign material, cornea, foreign object, corneal abrasion, globe perforation, ocular trauma, ocular injury, rust ring INTRODUCTIONBackgroundCorneal foreign body is foreign material on or in the cornea, usually metal, glass, or organic material. PathophysiologyCorneal foreign bodies generally fall under the category of minor ocular trauma. Small particles may become lodged in the corneal epithelium or stroma, particularly when projected toward the eye with considerable force. The foreign object may set off an inflammatory cascade, resulting in dilation of the surrounding vessels and subsequent edema of the lids, conjunctiva, and cornea. White blood cells also may be liberated, resulting in an anterior chamber reaction and/or corneal infiltration. If not removed, a foreign body can cause infection and/or tissue necrosis. FrequencyUnited StatesForeign bodies are one of the most frequent causes of visits for ophthalmic emergencies. Sometimes, the foreign body may not be present at the time of examination, having left the residual corneal abrasion with resultant pain. Superficial corneal foreign bodies are much more common than deeply embedded corneal foreign bodies. The physician must always consider the possibility of an intraocular foreign body when a patient presents with a history of trauma. In major league baseball, 33% of all eye injuries are corneal abrasions; in the National Basketball Association, corneal abrasions account for 12% of all eye traumas. InternationalNo difference in frequency is observed internationally. Mortality/MorbidityGenerally, superficial foreign bodies that are removed soon after the injury leave no permanent sequelae. However, corneal scarring or infection may occur. The longer the time interval between the injury and treatment, the greater the likelihood of complications. If the foreign body fully penetrates into the anterior or posterior chambers, then it is officially an intraocular foreign body. In this case, eye morbidity is much more common. Damage to the iris, lens, and retina can occur and severely damage vision. Any intraocular foreign body can lead to infection and endophthalmitis, a serious condition possibly leading to loss of the eye. SexSimilar to other traumatic injuries, the incidence in males is much higher than in females. AgeSimilar to most other traumatic injuries, the peak incidence is found in the second decade and generally occurs in people younger than 40 years. CLINICALHistoryThe activities of the patient and their surroundings are important. The time and the place of the injury, along with exactly how it occurred, are important. For example, a patient who was working with a high-speed grinding machine is likely to have an intraocular foreign body that may be occult in nature, whereas a patient who was working underneath a car when rust fell gently on the eye is likely to have only an external injury.
Physical
CausesCorneal foreign body injury can occur just about anywhere. They commonly occur both at home and at work.
DIFFERENTIALSCorneal Abrasion Foreign Body, Intraocular Keratitis, Bacterial Keratitis, Fungal
|
| Drug Name | Polymyxin B sulfate-trimethoprim (Polytrim) |
|---|---|
| Description | For ocular infections, involving cornea or conjunctiva, resulting from strains of microorganisms susceptible to this antibiotic. Available as a solution and ointment. Trimethoprim and polymyxin B are rarely sensitizing, and they have a wide spectrum of action in combination. Gram-positive: S aureus, S epidermidis, Streptococcus species (group A beta-hemolytic and nonhemolytic), S pneumoniae Gram-negative: P aeruginosa, H influenzae, H aegyptius, E coli, K pneumoniae, P mirabilis (indole-positive), Proteus species (indole-negative), E aerogenes, C freundii, C diversus, A calcoaceticus, M lacunata (some strains), S marcescens |
| Adult Dose | 1 gtt qid |
| Pediatric Dose | <2 months: Not established >2 months: 1 gtt qid |
| Contraindications | Documented hypersensitivity; viral, fungal, and mycobacterial infections of the eye |
| Interactions | None reported |
| Pregnancy | B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals |
| Precautions | Do not use in deep ocular infections or in those likely to become systemic; prolonged use of antibiotics or repeated therapy may result in bacterial or fungal overgrowth of nonsusceptible organism; if redness, irritation, swelling, or pain persists or increases, discontinue use immediately and reevaluate therapy; patient should avoid contamination of the dropper |
| Drug Name | Tobramycin (Tobrex) |
|---|---|
| Description | Like other aminoglycosides, the bactericidal activity of tobramycin is accomplished by specific inhibition of normal protein synthesis in susceptible bacteria, but very little presently is known about this action. May inhibit bacterial mRNA synthesis, causing inhibition of bacterial growth. |
| Adult Dose | 1 gtt qid |
| Pediatric Dose | Administer as in adults |
| Contraindications | Documented hypersensitivity |
| Interactions | Effects of this drug are decreased when used concurrently with gentamicin |
| Pregnancy | B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals |
| Precautions | Do not use in deep-seated ocular infections or in those that may become systemic; prolonged use of antibiotics may result in bacterial or fungal overgrowth of nonsusceptible organisms |
| Drug Name | Ofloxacin (Floxin) |
|---|---|
| Description | Pyridine carboxylic acid derivative with broad-spectrum bactericidal effect. |
| Adult Dose | 1 gtt qid |
| Pediatric Dose | Administer as in adults |
| Contraindications | Documented hypersensitivity |
| Interactions | None reported |
| Pregnancy | B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals |
| Precautions | Do not use in ocular infections that may become systemic; superinfections may occur with prolonged or repeated antibiotic therapy |
| Drug Name | Ciprofloxacin (Ciloxan) |
|---|---|
| Description | Inhibits bacterial growth by inhibiting DNA gyrase. |
| Adult Dose | 0.5-inch ribbon in subconjunctival sac qid |
| Pediatric Dose | Administer as in adults |
| Contraindications | Documented hypersensitivity; viral, mycobacterial, and fungal eye infections; avoid coadministration with steroid combinations after uncomplicated removal of a foreign body from cornea |
| Interactions | None reported |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus |
| Precautions | A white crystalline precipitate located in superficial portion of corneal defect may occur (onset starts in 1-7 d); precipitate usually is cleared within 2 wk and does not adversely affect clinical course or outcome; do not use in ocular infections that may become systemic; superinfections may occur with prolonged or repeated antibiotic therapy |
| Drug Name | Bacitracin ointment (AK-Tracin, Baciguent) |
|---|---|
| Description | Prevents transfer of mucopeptides into growing cell wall, inhibiting bacterial growth. |
| Adult Dose | 0.5-inch ribbon in subconjunctival sac qid |
| Pediatric Dose | Administer as in adults |
| Contraindications | Documented hypersensitivity; vaccinia, varicella, epithelial herpes simplex keratitis, mycobacterial infections, and fungal diseases of the eye; patients using steroid combinations after uncomplicated removal of a corneal foreign body |
| Interactions | None reported |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus |
| Precautions | Ophthalmic ointments may delay healing of corneal epithelia; in deep-seated infections of the eye, supplement with systemic medications; prolonged use may result in overgrowth of nonsusceptible organisms |
| Drug Name | Gatifloxacin (Zymar) |
|---|---|
| Description | Fourth-generation fluoroquinolone ophthalmic indicated for bacterial conjunctivitis. Elicits a dual mechanism of action by possessing an 8-methoxy group, thereby inhibiting the enzymes DNA gyrase and topoisomerase IV. DNA gyrase is involved in bacterial DNA replication, transcription, and repair. Topoisomerase IV is essential in chromosomal DNA partitioning during bacterial cell division. Indicated for bacterial conjunctivitis due to Corynebacterium propinquum, S aureus, Staphylococcus epidermidis, Streptococcus mitis, S pneumoniae, or H influenzae. |
| Adult Dose | Days 1-2: Instill 1 gtt into affected eye(s) q2h while awake; not to exceed 8 administrations/d Days 3-7: Instill 1 gtt into affected eye(s) up to 4 times/d while awake |
| Pediatric Dose | <1 year: Not established >1 year: Administer as in adults |
| Contraindications | Documented hypersensitivity |
| Interactions | None reported |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus |
| Precautions | For ophthalmic use only; commonly causes conjunctival irritation, increased lacrimation, corneal inflammation, or papillary conjunctivitis; less common adverse effects include conjunctival hemorrhage, dry eye, eye discharge, eye irritation, eye pain, eyelid swelling, headache, red eye, reduced visual acuity, or taste disturbance |
For comfort of the eye and to prevent iris adhesion in cases of traumatic iritis.
| Drug Name | Cyclopentolate HCl 0.5%-1.0% (Cyclogyl) |
|---|---|
| Description | Cyclopentolate is an anticholinergic agent that induces relaxation of the sphincter of the iris and ciliary muscles. When applied topically to the eyes, it causes rapid, intense cycloplegic and mydriatic effects that reach a peak in 15-60 min; recovery usually occurs within 24 h. The cycloplegic and mydriatic effects are slower in onset and longer in duration in patients who have dark pigmented irises. |
| Adult Dose | 1 gtt qd/tid |
| Pediatric Dose | Administer as in adults |
| Contraindications | Documented hypersensitivity; narrow-angle glaucoma |
| Interactions | Decreases effects of carbachol and cholinesterase inhibitors |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus |
| Precautions | Exercise caution in patients (eg, elderly patients) where increased intraocular pressure may be present; can cause toxic anticholinergic systemic adverse effects (common in children, especially infants) but incidence rare when used sparingly; compressing lacrimal sac by digital pressure for 1-3 min, following application, may minimize systemic absorption |
Article Last Updated: Nov 2, 2007